< %=imgalt%>
Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics
Home / Health News / 2007 / November 2007 / November 9, 2007
Cancers invisibility cloak against immune system discovered
Lung cancer

Anti-tobacco ads should either scare or disgust viewers: Study

China Medical Technologies Completes the Development of EGFR Molecular Diagnostic Kits

Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer

Popular cancer drug increases blood clot risk

More on Lung cancer

Health News

Sex, death form Oz Govts new anti-binge drinking campaign theme
A relationship between sex, death, and binge drinking forms the theme for the Australian Governments 20million-dollar campaign, which will target young drinkers as part of the National Binge Drinking Strategy. ANI

Moderate alcohol consumption beneficial for cardiovascular, cognitive health
Mild or moderate consumption of alcohol can have beneficial effects on the cardiovascular health and cognitive function of an individual, according to a new review. ANI

Doctors find worm in womans brain while operating for a tumour
Doctors in Arizona got surprised to find that there was a worm in the brain of a Phoenix-area woman they were operating to remove what they thought was a tumour. ANI

Cancers invisibility cloak against immune system discovered

Researchers at the University of British Columbia (UBC) have discovered a mechanism that creates an invisibility cloak for certain cancer cells and allows them to hide from the immune system.

Washington, Nov 9 : Researchers at the University of British Columbia (UBC) have discovered a mechanism that creates an "invisibility cloak" for certain cancer cells and allows them to hide from the immune system.

The research team found that metastatic tumours (cancers that spread from primary site) can evade the immune system via a process called chromatin remodeling. The invisibility mechanism operates in malignant carcinomas that include ovarian, prostate, melanoma and cervical cancers and is particularly active in breast and lung cancers.

"This discovery begins to address the mysteries of how cancer hides from the immune system and spreads -- it helps explain 20 years of observations in the field. It may offer whole new avenues for therapies," said Prof. Wilfred Jefferies, a member of UBC's Michael Smith Laboratories and Biomedical Research Centre.

Human DNA is packaged within each cell by chromatin, which is made up of DNA that encases proteins called histones.

The team discovered that in tumours, chromatin remodelling changes the structure of chromosomes by altering the histone codex or "instruction manual." These changes reduce production of receptors called MHC I molecules that display cancer-specific signals, or tags, recognized by the immune system.

When cancer-specific tags are not displayed, the cancer cells become "invisible" to the immune system and no defenses are mobilized -- the tumour cells are free to grow and spread. Furthermore, the high incidence of MHC I loss can be used as a predictor of rapid tumour growth progression and survival rates.

Jefferies said that the findings might lead, within five to 10 years, to new therapies that will force the cancer cells to "drop the cloak of invisibility" and be recognized by the immune system.

The research has recently been published in Molecular and Cellular Biology.

ANI

November 21, 2008

November 20, 2008

November 19, 2008

November 18, 2008

November 17, 2008

November 16, 2008